Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Cited by CrossRef (66)

  1. Haoxin Liu, Liang-Jun Yan. The Role of Ketone Bodies in Various Animal Models of Kidney Disease. Endocrines 2023;4:236
    https://doi.org/10.3390/endocrines4010019
  2. Mudasir Maqbool, Mohd Altaf Dar, Irfat Ara. Planting a path to kidney health: The vegetarian diet and diabetic nephropathy. 2023;4
    https://doi.org/10.1515/ohe-2023-0011
  3. Xichao Wang, Ruili Song, Zhuo Li. Salviolone protects against high glucose‐induced proliferation, oxidative stress, inflammation, and fibrosis of human renal mesangial cells by upregulating membrane metalloendopeptidase expression. Chem Biol Drug Des 2023;101:819
    https://doi.org/10.1111/cbdd.14183
  4. Hongyu Yu, Jian Ma, Yueru Gu, Wei Zou, Na Zhao. Serum cell division cycle 42 reflects the development and progression of diabetic nephropathy in patients with diabetes mellitus. Exp Ther Med 2024;27
    https://doi.org/10.3892/etm.2024.12473
  5. Zhiyue Zhu, Qi Zhang, Le Liu, Pengjie Bao, Shilin Liu, Chaoqun Song, Wenbo Yang, Zheng Nan. Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis. 2022;101:e31490
    https://doi.org/10.1097/MD.0000000000031490
  6. Kounaina Khan, Subrahmanya Padyana. Diabetic nephropathy: Ayur‐nutri‐pharmaco approach. Food Safety and Health 2024;2:344
    https://doi.org/10.1002/fsh3.12048
  7. Xialin Lv, Min Zhou, Xiu Liu, Qin Xiang, Rong Yu, Weijun Peng. Efficacy and Safety of Zhenwu Decoction in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1
    https://doi.org/10.1155/2022/2133705
  8. Zeinab Vahidinia, Abolfazl Azami Tameh, Shirin Barati, Melika Izadpanah, Elahe Seyed Hosseini. Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies. Cell Mol Biol Lett 2024;29
    https://doi.org/10.1186/s11658-024-00551-3
  9. Guohua Yang, Wang Yang, Hairong Jiang, Qing Yi, Wei Ma. Hederagenin inhibits high glucose‐induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression. Chem Biol Drug Des 2023;102:1409
    https://doi.org/10.1111/cbdd.14332
  10. Zelipha N. Kabubii, James Mucunu Mbaria, Peter Mbaabu Mathiu, John Muraba Wanjohi, Evans Nyaega Nyaboga. Bioassay guided isolation and compounds identification of the anti-diabetic fractions of (rosemary) Rosmarinus officinalis leaves extract. Clin Phytosci 2024;10
    https://doi.org/10.1186/s40816-024-00378-7
  11. V. Sharma, M. Khokhar, P. Panigrahi, A. Gadwal, P. Setia, P. Purohit. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy. Clinica Chimica Acta 2024;561:119842
    https://doi.org/10.1016/j.cca.2024.119842
  12. Lianqi Liu, Xingquan Pan, Fei Xie, Xin Xu, Dian Xiao, Junhai Xiao, Xinbo Zhou. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs. Bioorganic Chemistry 2022;124:105831
    https://doi.org/10.1016/j.bioorg.2022.105831
  13. Hongtu Hu, Wei Liang, Zongwei Zhang, Zikang Liu, Fan Chu, Yan Bao, Jialu Ran, Guohua Ding, Christian S. Goebl. The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease. International Journal of Endocrinology 2022;2022:1
    https://doi.org/10.1155/2022/2550744
  14. Wenyi Li, Zhenguo Liu, Min Song, Zhenpeng Shi, Jihang Zhang, Junyu Zhou, Yidan Liu, Yun Qiao, Deshan Liu. Mechanism of Yi-Qi-Bu-Shen Recipe for the Treatment of Diabetic Nephropathy Complicated with Cognitive Dysfunction Based on Network Pharmacology and Experimental Validation. DMSO 2024;Volume 17:3943
    https://doi.org/10.2147/DMSO.S481740
  15. Honglei Hu, Xiaodong Zhao, Xingqian Jin, Shujuan Wang, Wenlong Liang, Xiangguo Cong, Muhammad Tarek Abdel Ghafar. Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis. PLoS ONE 2022;17:e0265642
    https://doi.org/10.1371/journal.pone.0265642
  16. Shna Ahmed Mohhamed, Fatemeh Khadir, Zohreh Rahimi, Maryam Kohsari. Klotho G395A variants are associated with T2DM and diabetic nephropathy and influence on the levels of biochemical parameters. Gene Reports 2023;30:101733
    https://doi.org/10.1016/j.genrep.2022.101733
  17. Arvindkumar H. Chaurasiya, Meera R. Jaiswal, Santhakumari Bayatigeri, Shweta Kahar, Shalbha Tiwari, Ambika G. Unnikrishnan, Mahesh J. Kulkarni. Elevated Level of Glycated KQTALVELVK Peptide of Albumin Is Associated with the Risk of Diabetic Nephropathy. ACS Omega 2023;8:20654
    https://doi.org/10.1021/acsomega.3c01219
  18. Elham Ahmadi, Arya Afrooghe, Zahra Ebrahim Soltani, Mohammad Elahi, Maryam Shayan, Mohammad Amin Dabbagh Ohadi, Ahmad-Reza Dehpour. Beyond the lungs: Exploring diverse applications of bromhexine and ambroxol. Life Sciences 2024;353:122909
    https://doi.org/10.1016/j.lfs.2024.122909
  19. Che Yu, Zhuo Li, Cuili Nie, Lei Chang, Tao Jiang. Targeting Src homology phosphatase 2 ameliorates mouse diabetic nephropathy by attenuating ERK/NF-κB pathway-mediated renal inflammation. Cell Commun Signal 2023;21
    https://doi.org/10.1186/s12964-023-01394-9
  20. Jumana Gamal Abou Eleila, Amal Abdel Wahab Mohamed, Emam Abdalatif Waked, Laila Nessim Kamel, Hanan Shawky Amin, Hadeel Mohammad Elhanafi. Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy. Egypt J Med Hum Genet 2024;25
    https://doi.org/10.1186/s43042-024-00544-z
  21. Sitara Ghosh, Ankana Ghosh, Ashitha Rajanan, Amal Jyothy Suresh, Pratiksha Sharadrao Raut, Sourav Kundu, Bidya Dhar Sahu. Natural coumarins: Preclinical evidence-based potential candidates to alleviate diabetic nephropathy. Phytomedicine Plus 2022;2:100379
    https://doi.org/10.1016/j.phyplu.2022.100379
  22. Saheem Ahmad, Mohammad Faizan Ali Ahmad, Saif Khan, Sultan Alouffi, Mahvish Khan, Chander Prakash, Mohd Wajid Ali Khan, Irfan Ahmad Ansari. Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities. International Journal of Biological Macromolecules 2024;280:135761
    https://doi.org/10.1016/j.ijbiomac.2024.135761
  23. Aishwarya Padhye-Pendse, Rinku Umrani, Kishore Paknikar, Sachin Jadhav, Jyutika Rajwade. Zinc oxide nanoparticles prevent the onset of diabetic nephropathy by inhibiting multiple pathways associated with oxidative stress. Life Sciences 2024;347:122667
    https://doi.org/10.1016/j.lfs.2024.122667
  24. Alireza Mafi, Negar Yadegar, Marziyeh Salami, Raziyeh Salami, Omid Vakili, Esmat Aghadavod. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy. Pathology - Research and Practice 2021;227:153618
    https://doi.org/10.1016/j.prp.2021.153618
  25. 瑶瑶 任. Progress of Research on the Relationship between Serum sFRP-4 Levels and Connective Tissue Growth Factor and Type 2 Diabetic Nephropathy. ACM 2023;13:17584
    https://doi.org/10.12677/ACM.2023.13112464
  26. Jiarui Li, Jinyue Zhao, Chuanxi Tian, Lishuo Dong, Zezheng Kang, Jingshuo Wang, Shuang Zhao, Min Li, Xiaolin Tong. Mechanisms of regulation of glycolipid metabolism by natural compounds in plants: effects on short-chain fatty acids. Nutr Metab (Lond) 2024;21
    https://doi.org/10.1186/s12986-024-00829-5
  27. Inas R. El-Alameey, Renad N. Aljohani, Shoog A. Allhebi, Hadel A. Alahmadi, Rawan K. Alsakrani. Macronutrient Intake and Association with the Risk Factors of Diabetic Complications among People with Type 2 Diabetes Mellitus in Al-Madinah Al-Munawara. Open Access Maced J Med Sci 2024;12:73
    https://doi.org/10.3889/oamjms.2024.11743
  28. Ishfaq Ahmad Rather, Nadeem Khan, Ajay Singh Kushwah, Gurunath Surampalli, Manish Kumar. Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy. Life Sciences 2023;320:121543
    https://doi.org/10.1016/j.lfs.2023.121543
  29. Chenming Li, Lidong Gao, Chunxiao Lv, Ziqiang Li, Shanshan Fan, Xinyue Liu, Xinyi Rong, Yuhong Huang, Jia Liu. Active role of amino acid metabolism in early diagnosis and treatment of diabetic kidney disease. Front. Nutr. 2023;10
    https://doi.org/10.3389/fnut.2023.1239838
  30. Lingyu Du, Canghui Guo, Shengnan Zeng, Ke Yu, Maodong Liu, Ying Li. Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway. Renal Failure 2024;46
    https://doi.org/10.1080/0886022X.2024.2377785
  31. Vijayakumar Natesan, Sung-Jin Kim. The Trend of Organic Based Nanoparticles in the Treatment of Diabetes and Its Perspectives. Biomol Ther (Seoul) 2023;31:16
    https://doi.org/10.4062/biomolther.2022.080
  32. Oluwafemi A. Ojo, David Ajeigbe, Akingbolabo D. Ogunlakin, Olalekan E. Odesanmi, Mojisola Ayomipo, Godwin Berana, Peluola Ayeni, Omolola A. Ajayi-Odoko, Damilare I. Ayokunle, Adebola B. Ojo, Basiru O. Ajiboye, Omolara O. Ojo, Samuel O. Dahunsi. Preclinical antidiabetic and antioxidant effects of Erythrophleum africanum (benth.) harms in streptozotocin-induced diabetic nephropathy. 2024;21:349
    https://doi.org/10.1515/jcim-2024-0090
  33. Hosam M. Ahmad, Hussein S. Al-Fishawy, Inass Shaltout, Emad A. Abd Elnaeem, Asmaa S. Mohamed, Amel E. Salem. A comparative study between current and past Helicobacter pylori infection in terms of microalbuminuria in patients with type 2 diabetes. BMC Infect Dis 2024;24
    https://doi.org/10.1186/s12879-024-09918-5
  34. Anthony J. Evans, Yu-Long Li. Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics. IJMS 2024;25:12464
    https://doi.org/10.3390/ijms252212464
  35. Vijayakumar Natesan, Sung-Jin Kim. Metabolic Bone Diseases and New Drug Developments. Biomol Ther (Seoul) 2022;30:309
    https://doi.org/10.4062/biomolther.2022.007
  36. Ying Gao, Zhaoan Guo, Yingying Liu. Analysis of the potential molecular biology of triptolide in the treatment of diabetic nephropathy: A narrative review. 2022;101:e31941
    https://doi.org/10.1097/MD.0000000000031941
  37. Zhi-Min Lin, Han-Yuan Gao, Shu-Han Shi, Yue-Ting Li. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. World J Diabetes 2025;16
    https://doi.org/10.4239/wjd.v16.i1.92711
  38. Zili Kong, Wenshan Lv, Yunyang Wang, Yajing Huang, Kui Che, Huiqi Nan, Yu Xin, Jiaxuan Wang, Jintao Chen, Yangang Wang, Jingwei Chi. Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo. J Biochem & Molecular Tox 2023;37
    https://doi.org/10.1002/jbt.23445
  39. Daniel Benak, Stepanka Benakova, Lydie Plecita-Hlavata, Marketa Hlavackova. The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1223583
  40. О.А. Olenovych. Peculiarities of ionoregulatory renal function of rats in the dynamics of experimental diabetes mellitus development. Mìžnarodnij endokrinologìčnij žurnal 2023;19:118
    https://doi.org/10.22141/2224-0721.19.2.2023.1256
  41. Patutong Chatchawal, Patcharaporn Tippayawat, Thidarat Somdee, Sawinee Ngernpimai, Molin Wongwattanakul, Nattaya Sae-ung, Sirirat Anutrakulchai, Ratthaphol Kraiklang. Urinary cyclophilin A as an early marker of chronic kidney disease with underlying type 2 diabetes. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-73994-5
  42. Sanjesh Kumar, Mansi Singh, Pooja S. Murkute, Ananya Chakraborty, Arshad Farid, Hafiza Sehrish Kiani, Farzad Taghizadeh‐Hesary, Mithun Bhowmick, Sumel Ashique. Role of Flavonoids in Chronic Metabolic Diseases. 2024.
    https://doi.org/10.1002/9781394238071.ch8
  43. . .
    https://doi.org/
  44. Xiatiguli Taximaimaiti, Rahima Abdulla, Xuelei Xin, Yuan Zhao, Yi Liu, Haji Akber Aisa, Deqiang Deng, Tao Wu. Rapid identification of chemical components in Xuelian granule by UHPLC-Q-orbitrap-HRMS based on enzyme activity in vitro. BMC Complement Med Ther 2023;23
    https://doi.org/10.1186/s12906-023-04025-5
  45. Qiuli Wang, Yan Zhou, Nan Zheng, Feng Jiang, Chenxia Juan. Identification of hub genes associated with pyroptosis in diabetic nephropathy patients using integrated bioinformatic analysis. Int Urol Nephrol 2024
    https://doi.org/10.1007/s11255-024-04158-7
  46. Philanathi Mabena, Thandi M. D. Fasemore, Pilani Nkomozepi. Impact of Nutraceuticals on Type 1 and Type 2 Diabetes Mellitus-Induced Micro- and Macrovasculopathies. Applied Sciences 2023;14:64
    https://doi.org/10.3390/app14010064
  47. Ayudia Cipta Khairani, Tri Wijayanti, Gunawan Pamudji Widodo. Antihyperglycemic Activity of Red Fruit Oil (Pandanus conoideus Lam) on Improving Kidney Function in STZ- NA-Induced Nephropathy Rats. JFIKI 2023;10:173
    https://doi.org/10.20473/jfiki.v10i22023.173-183
  48. Meiling Fan, Xintian Lan, Qunling Wang, Mengyao Shan, Xiaoxue Fang, Yegang Zhang, Donglu Wu, Haoming Luo, Wenyi Gao, Difu Zhu. Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives. Front. Pharmacol. 2023;14
    https://doi.org/10.3389/fphar.2023.1070738
  49. Qiong Wang, Yanting Zhu, Qianlan Dong, Linping Zhang, Wei Zhang. A Novel Circ_Arf3/miR-452-5p/Mbnl1 Axis Regulates Proliferation and Expression of Fibrosis-Related Proteins of Mouse Mesangial Cells Under High Glucose. DMSO 2023;Volume 16:2105
    https://doi.org/10.2147/DMSO.S400530
  50. Antonio Simone Laganà, Samuel H. Myers, Gianpiero Forte, Antoine Naem, Harald Krentel, Leila Allahqoli, Ibrahim Alkatout, Vittorio Unfer. Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future. Expert Opinion on Drug Metabolism & Toxicology 2024;20:61
    https://doi.org/10.1080/17425255.2024.2306851
  51. Ying Huang, Wen Lu, Hongyun Lu. The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy. Diabetol Metab Syndr 2022;14
    https://doi.org/10.1186/s13098-022-00815-y
  52. Vijay Viswanathan, Reshma Mirshad. The burden of diabetic nephropathy in India: Need for prevention. 2023;3:25
    https://doi.org/10.2478/dine-2023-0003
  53. Sulin F. Kamt, Jiankang Liu, Liang-Jun Yan. Renal-Protective Roles of Lipoic Acid in Kidney Disease. Nutrients 2023;15:1732
    https://doi.org/10.3390/nu15071732
  54. Ileana Peride, Miruna Anastasiu, Silvia Alexandra Serban, Mirela Tiglis, Razvan Ene, Ana-Maria Nechita, Tiberiu Paul Neagu, Ionel Alexandru Checherita, Andrei Niculae. The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease—A Challenge for Physicians and Patients. JPM 2024;14:778
    https://doi.org/10.3390/jpm14080778
  55. Keke Zhang, Xinxing Wan, Md Asaduzzaman Khan, Xiaoying Sun, Xuan Yi, Zhouqi Wang, Ke Chen, Lin Peng. Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy. DMSO 2022;Volume 15:2789
    https://doi.org/10.2147/DMSO.S384054
  56. Liang-Jun Yan. The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features. Biomolecules 2022;12:1225
    https://doi.org/10.3390/biom12091225
  57. Ning Li, Xuenan Liu, Hao Wang, Yingling Duan, Yu Zhang, Ping Zhou, Haofu Dai, Tian Lan. “Qi Nan” agarwood restores podocyte autophagy in diabetic kidney disease by targeting EGFR signaling pathway. Chin Med 2024;19
    https://doi.org/10.1186/s13020-024-00923-z
  58. Shokoufeh Abbasi, Masoud Amini, Sahar Vahdat, Ashraf Aminorroaya, Mojgan Mortazavi, Fatemeh Azimi. Prevalence, Incidence, and Risk Factors of Nephropathy in Patients with Prediabetes: Family History of Diabetes Mellitus Is Not Associated with Increased Risk of Nephropathy. Jundishapur J Chronic Dis Care 2024;13
    https://doi.org/10.5812/jjcdc-142750
  59. Tingting Lin, Yuze Zhang, Qifeng Wei, Zugui Huang. GLP‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy. Clin Exp Pharma Physio 2024;51
    https://doi.org/10.1111/1440-1681.70003
  60. Tae Yeon Kim, Ranjit De, Inhoo Choi, Hyemin Kim, Sei Kwang Hahn. Multifunctional nanomaterials for smart wearable diabetic healthcare devices. Biomaterials 2024;310:122630
    https://doi.org/10.1016/j.biomaterials.2024.122630
  61. Wei Mi, Min Yu, Shuying Yin, Yuhan Ji, Tala Shi, Ning Li, Jian Song. Analysis of the Renal Protection and Antioxidative Stress Effects of Panax notoginseng Saponins in Diabetic Nephropathy Mice. Journal of Immunology Research 2022;2022:1
    https://doi.org/10.1155/2022/3610935
  62. Deepak Kumar, Pinaki Dutta, Raja Ramachandran, Rajasri Bhattacharyya, Dibyajyoti Banerjee. Excreted albumin of diabetic microalbuminuria cases exhibits pseudo esterase activity: A new way to explore microalbuminuria, perhaps with more information. Clinica Chimica Acta 2025;565:119947
    https://doi.org/10.1016/j.cca.2024.119947
  63. Magdalena Król-Kulikowska, Mirosław Banasik, Marta Kepinska. The Effect of Selected Nitric Oxide Synthase Polymorphisms on the Risk of Developing Diabetic Nephropathy. Antioxidants 2024;13:838
    https://doi.org/10.3390/antiox13070838
  64. Amirhossein Yadegar, Fatemeh Mohammadi, Soghra Rabizadeh, Aryan Ayati, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Alireza Esteghamati, Manouchehr Nakhjavani. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort. Clinical Laboratory Analysis 2023;37
    https://doi.org/10.1002/jcla.24954
  65. Vijayakumar Natesan, Sung-Jin Kim. Lipid Metabolism, Disorders and Therapeutic Drugs - Review. Biomol Ther (Seoul) 2021;29:596
    https://doi.org/10.4062/biomolther.2021.122
  66. Martin Buysschaert, Anne-Sophie Boureau, Yasmin Dhane, Bernard Bauduceau. Particularités des complications microangiopathiques du diabète chez le sujet âgé. Médecine des Maladies Métaboliques 2023;17:8S49
    https://doi.org/10.1016/S1957-2557(23)00297-3